Zoledronic Acid Injection, Solution, Concentrate
Product Images NDC 68001-610

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 68001-610). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Figure 1 Zole)

A bar chart titled 'Proportion of Complete Responders by Day 10 in Pooled HCM Studies' comparing Zoledronic acid injection 4 mg (n=86) and Pamidronate 90 mg (n=99). The y-axis shows the percentage of complete responders from 0% to 100%. Zoledronic acid reaches about 85%, while Pamidronate is around 65%. A p-value of 0.002 is indicated comparing the two groups.*

FDA Label Image

Structure (Stru Zole)

Chemical structure diagram of zoledronic acid, showing the molecular arrangement including nitrogen-containing rings and phosphonic acid groups.*

FDA Label Image

Zolderonic Acid Inj 4mg/5ml Carton (Zole Carton)

Packaging label for Zoledronic Acid injection, 4 mg/5 mL (0.8 mg/mL) solution concentrate for intravenous infusion. The label includes dosage instructions, storage conditions, and manufacturer information from BluePoint Laboratories. The label specifies this product is Rx only and for single-dose use in a 5 mL vial.*

FDA Label Image

Image Description (Zole Formula)

A formula depicting the calculation of Creatinine Clearance (CrCl), including variables for age, weight, serum creatinine, and a gender adjustment factor for female patients, presented in clinical measurement units.*

FDA Label Image

Zoledronic Acid Inj 4mg/5ml (Zole Label)

Label for Zoledronic Acid Injection, 4 mg/5 mL (0.8 mg/mL) concentrate for intravenous infusion. The single-dose 5 mL vial is sterile and must be diluted prior to use, not for direct injection. Manufactured by Emcure Pharmaceuticals Ltd. for BluePoint Laboratories.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.